Javascript doit fonctionner ! Activez-le et rechargez cette page.
Le Rézo de JeuxDeMots
• Types de relations
• Types de noeuds
• Consolider
le terme
  Options  
             

  Filtrage type relations : +   - (ex: 4, 12, 18, 36, 444, 555, 777)
  Filtrage valeur :          min   max
  Filtrage type noeuds :   +   - (ex: 4, 6, 8, 9, 10, 12, 18, 36, 444, 555, 777)

  Présentation de sortie :   (ex: -rien-, cloud, nicecloud)
 

'en:dna probes, hla'
(id=6750489 ; fe=en:dna probes, hla ; type=1 ; niveau=200 ; luminosité=25 ; somme entrante=1361 creation date=2017-06-22 touchdate=2025-07-15 20:38:15.000)
≈ 46 relations sortantes

  1. en:dna probes, hla -- r_associated #0: 38 / 1 -> en:analysis aspect
    n1=en:dna probes, hla | n2=en:analysis aspect | rel=r_associated | relid=0 | w=38
  2. en:dna probes, hla -- r_associated #0: 37 / 0.974 -> en:chemical aspects
    n1=en:dna probes, hla | n2=en:chemical aspects | rel=r_associated | relid=0 | w=37
  3. en:dna probes, hla -- r_associated #0: 37 / 0.974 -> en:pml/rara single fusion probe
    n1=en:dna probes, hla | n2=en:pml/rara single fusion probe | rel=r_associated | relid=0 | w=37
  4. en:dna probes, hla -- r_associated #0: 37 / 0.974 -> en:standards characteristics
    n1=en:dna probes, hla | n2=en:standards characteristics | rel=r_associated | relid=0 | w=37
  5. en:dna probes, hla -- r_associated #0: 36 / 0.947 -> en:mechanism of action qualifier
    n1=en:dna probes, hla | n2=en:mechanism of action qualifier | rel=r_associated | relid=0 | w=36
  6. en:dna probes, hla -- r_associated #0: 35 / 0.921 -> en:cellular secretion
    n1=en:dna probes, hla | n2=en:cellular secretion | rel=r_associated | relid=0 | w=35
  7. en:dna probes, hla -- r_associated #0: 35 / 0.921 -> en:contraindications aspect
    n1=en:dna probes, hla | n2=en:contraindications aspect | rel=r_associated | relid=0 | w=35
  8. en:dna probes, hla -- r_associated #0: 35 / 0.921 -> en:toxicity aspects
    n1=en:dna probes, hla | n2=en:toxicity aspects | rel=r_associated | relid=0 | w=35
  9. en:dna probes, hla -- r_associated #0: 34 / 0.895 -> en:dna probes, hla-dw
    n1=en:dna probes, hla | n2=en:dna probes, hla-dw | rel=r_associated | relid=0 | w=34
  10. en:dna probes, hla -- r_associated #0: 34 / 0.895 -> en:poisoning aspects
    n1=en:dna probes, hla | n2=en:poisoning aspects | rel=r_associated | relid=0 | w=34
  11. en:dna probes, hla -- r_associated #0: 32 / 0.842 -> en:aspects of radiation effects
    n1=en:dna probes, hla | n2=en:aspects of radiation effects | rel=r_associated | relid=0 | w=32
  12. en:dna probes, hla -- r_associated #0: 32 / 0.842 -> en:dna primers
    n1=en:dna probes, hla | n2=en:dna primers | rel=r_associated | relid=0 | w=32
  13. en:dna probes, hla -- r_associated #0: 32 / 0.842 -> en:dna probes, hla-a
    n1=en:dna probes, hla | n2=en:dna probes, hla-a | rel=r_associated | relid=0 | w=32
  14. en:dna probes, hla -- r_associated #0: 32 / 0.842 -> en:dna probes, hla-c
    n1=en:dna probes, hla | n2=en:dna probes, hla-c | rel=r_associated | relid=0 | w=32
  15. en:dna probes, hla -- r_associated #0: 32 / 0.842 -> en:dna probes, hla-dr
    n1=en:dna probes, hla | n2=en:dna probes, hla-dr | rel=r_associated | relid=0 | w=32
  16. en:dna probes, hla -- r_associated #0: 32 / 0.842 -> en:in urine
    n1=en:dna probes, hla | n2=en:in urine | rel=r_associated | relid=0 | w=32
  17. en:dna probes, hla -- r_associated #0: 31 / 0.816 -> en:hpv dna probes
    n1=en:dna probes, hla | n2=en:hpv dna probes | rel=r_associated | relid=0 | w=31
  18. en:dna probes, hla -- r_associated #0: 31 / 0.816 -> en:in cerebrospinal fluid
    n1=en:dna probes, hla | n2=en:in cerebrospinal fluid | rel=r_associated | relid=0 | w=31
  19. en:dna probes, hla -- r_associated #0: 30 / 0.789 -> en:chemical synthesis
    n1=en:dna probes, hla | n2=en:chemical synthesis | rel=r_associated | relid=0 | w=30
  20. en:dna probes, hla -- r_associated #0: 30 / 0.789 -> en:dna probes, hla-d
    n1=en:dna probes, hla | n2=en:dna probes, hla-d | rel=r_associated | relid=0 | w=30
  21. en:dna probes, hla -- r_associated #0: 30 / 0.789 -> en:exposure as collected domain
    n1=en:dna probes, hla | n2=en:exposure as collected domain | rel=r_associated | relid=0 | w=30
  22. en:dna probes, hla -- r_associated #0: 30 / 0.789 -> en:physiological aspects
    n1=en:dna probes, hla | n2=en:physiological aspects | rel=r_associated | relid=0 | w=30
  23. en:dna probes, hla -- r_associated #0: 30 / 0.789 -> en:pml/rara dual fusion probe
    n1=en:dna probes, hla | n2=en:pml/rara dual fusion probe | rel=r_associated | relid=0 | w=30
  24. en:dna probes, hla -- r_associated #0: 29 / 0.763 -> en:bioformation
    n1=en:dna probes, hla | n2=en:bioformation | rel=r_associated | relid=0 | w=29
  25. en:dna probes, hla -- r_associated #0: 29 / 0.763 -> en:cdna
    n1=en:dna probes, hla | n2=en:cdna | rel=r_associated | relid=0 | w=29
  26. en:dna probes, hla -- r_associated #0: 29 / 0.763 -> en:dna probes, hla-b
    n1=en:dna probes, hla | n2=en:dna probes, hla-b | rel=r_associated | relid=0 | w=29
  27. en:dna probes, hla -- r_associated #0: 29 / 0.763 -> en:historical aspects qualifier
    n1=en:dna probes, hla | n2=en:historical aspects qualifier | rel=r_associated | relid=0 | w=29
  28. en:dna probes, hla -- r_associated #0: 29 / 0.763 -> en:immunology aspects
    n1=en:dna probes, hla | n2=en:immunology aspects | rel=r_associated | relid=0 | w=29
  29. en:dna probes, hla -- r_associated #0: 29 / 0.763 -> en:therapeutic use - qualifier
    n1=en:dna probes, hla | n2=en:therapeutic use - qualifier | rel=r_associated | relid=0 | w=29
  30. en:dna probes, hla -- r_associated #0: 29 / 0.763 -> en:ultrastructure
    n1=en:dna probes, hla | n2=en:ultrastructure | rel=r_associated | relid=0 | w=29
  31. en:dna probes, hla -- r_associated #0: 28 / 0.737 -> en:aspects of adverse effects
    n1=en:dna probes, hla | n2=en:aspects of adverse effects | rel=r_associated | relid=0 | w=28
  32. en:dna probes, hla -- r_associated #0: 28 / 0.737 -> en:cep 7 probe
    n1=en:dna probes, hla | n2=en:cep 7 probe | rel=r_associated | relid=0 | w=28
  33. en:dna probes, hla -- r_associated #0: 28 / 0.737 -> en:drug effect
    n1=en:dna probes, hla | n2=en:drug effect | rel=r_associated | relid=0 | w=28
  34. en:dna probes, hla -- r_associated #0: 28 / 0.737 -> en:in blood
    n1=en:dna probes, hla | n2=en:in blood | rel=r_associated | relid=0 | w=28
  35. en:dna probes, hla -- r_associated #0: 28 / 0.737 -> en:metabolic aspects
    n1=en:dna probes, hla | n2=en:metabolic aspects | rel=r_associated | relid=0 | w=28
  36. en:dna probes, hla -- r_associated #0: 28 / 0.737 -> en:pharmacokinetic aspects
    n1=en:dna probes, hla | n2=en:pharmacokinetic aspects | rel=r_associated | relid=0 | w=28
  37. en:dna probes, hla -- r_associated #0: 28 / 0.737 -> en:rara dual color break-apart rearrangement probe
    n1=en:dna probes, hla | n2=en:rara dual color break-apart rearrangement probe | rel=r_associated | relid=0 | w=28
  38. en:dna probes, hla -- r_associated #0: 28 / 0.737 -> en:taxonomic
    n1=en:dna probes, hla | n2=en:taxonomic | rel=r_associated | relid=0 | w=28
  39. en:dna probes, hla -- r_associated #0: 27 / 0.711 -> en:dna probes
    n1=en:dna probes, hla | n2=en:dna probes | rel=r_associated | relid=0 | w=27
  40. en:dna probes, hla -- r_associated #0: 27 / 0.711 -> en:genetic aspects
    n1=en:dna probes, hla | n2=en:genetic aspects | rel=r_associated | relid=0 | w=27
  41. en:dna probes, hla -- r_associated #0: 26 / 0.684 -> en:chromosome 17 centromere probe
    n1=en:dna probes, hla | n2=en:chromosome 17 centromere probe | rel=r_associated | relid=0 | w=26
  42. en:dna probes, hla -- r_associated #0: 25 / 0.658 -> en:dna
    n1=en:dna probes, hla | n2=en:dna | rel=r_associated | relid=0 | w=25
  43. en:dna probes, hla -- r_associated #0: 20 / 0.526 -> amorces d'adn
    n1=en:dna probes, hla | n2=amorces d'adn | rel=r_associated | relid=0 | w=20
  44. en:dna probes, hla -- r_associated #0: 20 / 0.526 -> amorceurs d'adn
    n1=en:dna probes, hla | n2=amorceurs d'adn | rel=r_associated | relid=0 | w=20
  45. en:dna probes, hla -- r_associated #0: 20 / 0.526 -> effet d'un médicament
    n1=en:dna probes, hla | n2=effet d'un médicament | rel=r_associated | relid=0 | w=20
  46. en:dna probes, hla -- r_associated #0: 2 / 0.053 -> en:nucleic acid, nucleoside, or nucleotide
    n1=en:dna probes, hla | n2=en:nucleic acid, nucleoside, or nucleotide | rel=r_associated | relid=0 | w=2
≈ 45 relations entrantes

  1. amorceurs d'adn --- r_associated #0: 50 --> en:dna probes, hla
    n1=amorceurs d'adn | n2=en:dna probes, hla | rel=r_associated | relid=0 | w=50
  2. en:dna primers --- r_associated #0: 49 --> en:dna probes, hla
    n1=en:dna primers | n2=en:dna probes, hla | rel=r_associated | relid=0 | w=49
  3. amorces d'adn --- r_associated #0: 44 --> en:dna probes, hla
    n1=amorces d'adn | n2=en:dna probes, hla | rel=r_associated | relid=0 | w=44
  4. en:dna probes, hla-dr --- r_associated #0: 41 --> en:dna probes, hla
    n1=en:dna probes, hla-dr | n2=en:dna probes, hla | rel=r_associated | relid=0 | w=41
  5. effet d'un médicament --- r_associated #0: 40 --> en:dna probes, hla
    n1=effet d'un médicament | n2=en:dna probes, hla | rel=r_associated | relid=0 | w=40
  6. en:drug effect --- r_associated #0: 39 --> en:dna probes, hla
    n1=en:drug effect | n2=en:dna probes, hla | rel=r_associated | relid=0 | w=39
  7. en:dna probes, hla-b --- r_associated #0: 34 --> en:dna probes, hla
    n1=en:dna probes, hla-b | n2=en:dna probes, hla | rel=r_associated | relid=0 | w=34
  8. en:dna probes, hla-c --- r_associated #0: 34 --> en:dna probes, hla
    n1=en:dna probes, hla-c | n2=en:dna probes, hla | rel=r_associated | relid=0 | w=34
  9. en:therapeutic use - qualifier --- r_associated #0: 34 --> en:dna probes, hla
    n1=en:therapeutic use - qualifier | n2=en:dna probes, hla | rel=r_associated | relid=0 | w=34
  10. en:dna probes, hla-dw --- r_associated #0: 31 --> en:dna probes, hla
    n1=en:dna probes, hla-dw | n2=en:dna probes, hla | rel=r_associated | relid=0 | w=31
  11. en:mechanism of action qualifier --- r_associated #0: 31 --> en:dna probes, hla
    n1=en:mechanism of action qualifier | n2=en:dna probes, hla | rel=r_associated | relid=0 | w=31
  12. en:pml/rara dual fusion probe --- r_associated #0: 31 --> en:dna probes, hla
    n1=en:pml/rara dual fusion probe | n2=en:dna probes, hla | rel=r_associated | relid=0 | w=31
  13. en:aspects of adverse effects --- r_associated #0: 30 --> en:dna probes, hla
    n1=en:aspects of adverse effects | n2=en:dna probes, hla | rel=r_associated | relid=0 | w=30
  14. en:exposure as collected domain --- r_associated #0: 30 --> en:dna probes, hla
    n1=en:exposure as collected domain | n2=en:dna probes, hla | rel=r_associated | relid=0 | w=30
  15. en:hpv dna probes --- r_associated #0: 30 --> en:dna probes, hla
    n1=en:hpv dna probes | n2=en:dna probes, hla | rel=r_associated | relid=0 | w=30
  16. en:in urine --- r_associated #0: 30 --> en:dna probes, hla
    n1=en:in urine | n2=en:dna probes, hla | rel=r_associated | relid=0 | w=30
  17. en:rara dual color break-apart rearrangement probe --- r_associated #0: 30 --> en:dna probes, hla
    n1=en:rara dual color break-apart rearrangement probe | n2=en:dna probes, hla | rel=r_associated | relid=0 | w=30
  18. en:cellular secretion --- r_associated #0: 29 --> en:dna probes, hla
    n1=en:cellular secretion | n2=en:dna probes, hla | rel=r_associated | relid=0 | w=29
  19. en:chemical synthesis --- r_associated #0: 29 --> en:dna probes, hla
    n1=en:chemical synthesis | n2=en:dna probes, hla | rel=r_associated | relid=0 | w=29
  20. en:historical aspects qualifier --- r_associated #0: 29 --> en:dna probes, hla
    n1=en:historical aspects qualifier | n2=en:dna probes, hla | rel=r_associated | relid=0 | w=29
  21. en:pharmacokinetic aspects --- r_associated #0: 29 --> en:dna probes, hla
    n1=en:pharmacokinetic aspects | n2=en:dna probes, hla | rel=r_associated | relid=0 | w=29
  22. en:standards characteristics --- r_associated #0: 29 --> en:dna probes, hla
    n1=en:standards characteristics | n2=en:dna probes, hla | rel=r_associated | relid=0 | w=29
  23. en:taxonomic --- r_associated #0: 29 --> en:dna probes, hla
    n1=en:taxonomic | n2=en:dna probes, hla | rel=r_associated | relid=0 | w=29
  24. en:contraindications aspect --- r_associated #0: 28 --> en:dna probes, hla
    n1=en:contraindications aspect | n2=en:dna probes, hla | rel=r_associated | relid=0 | w=28
  25. en:immunology aspects --- r_associated #0: 28 --> en:dna probes, hla
    n1=en:immunology aspects | n2=en:dna probes, hla | rel=r_associated | relid=0 | w=28
  26. en:in cerebrospinal fluid --- r_associated #0: 28 --> en:dna probes, hla
    n1=en:in cerebrospinal fluid | n2=en:dna probes, hla | rel=r_associated | relid=0 | w=28
  27. en:physiological aspects --- r_associated #0: 28 --> en:dna probes, hla
    n1=en:physiological aspects | n2=en:dna probes, hla | rel=r_associated | relid=0 | w=28
  28. en:bioformation --- r_associated #0: 27 --> en:dna probes, hla
    n1=en:bioformation | n2=en:dna probes, hla | rel=r_associated | relid=0 | w=27
  29. en:dna probes, hla-d --- r_associated #0: 27 --> en:dna probes, hla
    n1=en:dna probes, hla-d | n2=en:dna probes, hla | rel=r_associated | relid=0 | w=27
  30. en:analysis aspect --- r_associated #0: 26 --> en:dna probes, hla
    n1=en:analysis aspect | n2=en:dna probes, hla | rel=r_associated | relid=0 | w=26
  31. en:dna probes --- r_associated #0: 26 --> en:dna probes, hla
    n1=en:dna probes | n2=en:dna probes, hla | rel=r_associated | relid=0 | w=26
  32. en:dna probes, hla-a --- r_associated #0: 26 --> en:dna probes, hla
    n1=en:dna probes, hla-a | n2=en:dna probes, hla | rel=r_associated | relid=0 | w=26
  33. en:poisoning aspects --- r_associated #0: 26 --> en:dna probes, hla
    n1=en:poisoning aspects | n2=en:dna probes, hla | rel=r_associated | relid=0 | w=26
  34. en:in blood --- r_associated #0: 25 --> en:dna probes, hla
    n1=en:in blood | n2=en:dna probes, hla | rel=r_associated | relid=0 | w=25
  35. en:metabolic aspects --- r_associated #0: 25 --> en:dna probes, hla
    n1=en:metabolic aspects | n2=en:dna probes, hla | rel=r_associated | relid=0 | w=25
  36. en:ultrastructure --- r_associated #0: 25 --> en:dna probes, hla
    n1=en:ultrastructure | n2=en:dna probes, hla | rel=r_associated | relid=0 | w=25
  37. en:chromosome 17 centromere probe --- r_associated #0: 24 --> en:dna probes, hla
    n1=en:chromosome 17 centromere probe | n2=en:dna probes, hla | rel=r_associated | relid=0 | w=24
  38. en:pml/rara single fusion probe --- r_associated #0: 24 --> en:dna probes, hla
    n1=en:pml/rara single fusion probe | n2=en:dna probes, hla | rel=r_associated | relid=0 | w=24
  39. en:cdna --- r_associated #0: 23 --> en:dna probes, hla
    n1=en:cdna | n2=en:dna probes, hla | rel=r_associated | relid=0 | w=23
  40. en:cep 7 probe --- r_associated #0: 23 --> en:dna probes, hla
    n1=en:cep 7 probe | n2=en:dna probes, hla | rel=r_associated | relid=0 | w=23
  41. en:genetic aspects --- r_associated #0: 23 --> en:dna probes, hla
    n1=en:genetic aspects | n2=en:dna probes, hla | rel=r_associated | relid=0 | w=23
  42. en:aspects of radiation effects --- r_associated #0: 22 --> en:dna probes, hla
    n1=en:aspects of radiation effects | n2=en:dna probes, hla | rel=r_associated | relid=0 | w=22
  43. en:chemical aspects --- r_associated #0: 22 --> en:dna probes, hla
    n1=en:chemical aspects | n2=en:dna probes, hla | rel=r_associated | relid=0 | w=22
  44. en:toxicity aspects --- r_associated #0: 21 --> en:dna probes, hla
    n1=en:toxicity aspects | n2=en:dna probes, hla | rel=r_associated | relid=0 | w=21
  45. taxinomique --- r_associated #0: 10 --> en:dna probes, hla
    n1=taxinomique | n2=en:dna probes, hla | rel=r_associated | relid=0 | w=10
Le service Rézo permet d'énumérer les relations existant pour un terme. Ce service est interrogeable par programme.
Projet JeuxDeMots - url: http://www.jeuxdemots.org
contact: mathieu.lafourcade@lirmm.fr